Table 1b.
Baseline demographic and clinical data of biomarker population in the venlafaxine study (SND103285)
Biomarker population | ||||
---|---|---|---|---|
Venlafaxine (N = 51) | Placebo (N = 53) | Total (N = 104) | ||
Age | Mean | 44.80 | 44.53 | 44.66 |
SD | 11.10 | 10.46 | 10.78 | |
Min | 21 | 19 | 19 | |
Max | 63 | 60 | 63 | |
Sex | Female | 29 (57%) | 35 (66%) | 64 (62%) |
Male | 22 (43%) | 18 (34%) | 40 (38%) | |
HAM-D | Mean | 23.62 | 24.45 | 24.05 |
SD | 4.16 | 4.20 | 4.20 | |
Min | 16 | 16 | 16 | |
Max | 34 | 33 | 34 |